Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015
Authors' conclusion
In China, there is a high prevalence of HTN and pre-HTN, and awareness, treatment, and control of HTN were low.
Study context
- Population
- Residents ≥18 years of age from 31 provinces in mainland China, 2012–2015
- Participants
- 451,755 residents
- Outcome
- Prevalence of HTN (SBP ≥140 mm Hg or DBP ≥90 mm Hg or antihypertensive medication within 2 weeks)
Methodological detailsnationwide survey, stratified multistage random sampling, nationally representative
- Nationwide survey
- Stratified multistage random sampling
- Nationally representative
Main finding
As reported in the abstract
HTN prevalence (Chinese guideline)
Hypertension (HTN) prevalence (≈244.5 million adults)
23.2%
Pre-HTN prevalence (≈435.3 million adults)
41.3%
Observational data: associations, not effects.
Further findings
HTN prevalence, urban vs rural · no significant difference
P = 0.819
Awareness, treatment and control among individuals with HTN
- Aware of condition
- 46.9%
- Taking prescribed antihypertensive medications
- 40.7%
- Controlled HTN
- 15.3%
Antihypertensive medication use
- Calcium channel blockers most common monotherapy
- 46.5%
- Treated patients using ≥2 medications
- 31.7%
HTN by 2017 ACC/AHA guideline (systolic BP (SBP) ≥130 or diastolic BP (DBP) ≥80 mm Hg)
- Prevalence (twice that by 2010 Chinese guideline)
- 46.4%
- Control rate (SBP <130 and DBP <80 mm Hg)
- 3.0%
Original publication
Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015. Circulation. Published 15 February 2018. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →